ArticleVaccines2022

Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.

Sutima Luangdilok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.